Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus infections. However, the ongoing evolution of the virus regularly produces new variants that are ...
May 26, 2025
0
25
Researchers have developed a first-of-its-kind device to profile the immune function of newborns. Using a single drop of blood, the BiophysicaL Immune Profiling for Infants (BLIPI) system provides real-time insights into ...
May 26, 2025
0
68
A breakthrough study, led by scientists at Waipapa Taumata Rau, University of Auckland, has uncovered how daylight can boost the immune system's ability to fight infections.
May 23, 2025
0
178
Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not well understood. In a new study published in Cell Genomics, researchers at Baylor College of Medicine ...
May 23, 2025
0
53
Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are currently difficult or impossible to treat—for example, aggressive forms of cancer or rare diseases ...
May 27, 2025
0
0
B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric leukemia cases. According to REDECAN, more than 400 new cases are estimated to be diagnosed in Spain ...
May 27, 2025
0
0
A study appearing in Nature investigated the role of astrocytes, an abundant cell type in the brain, in regulating an immune response against glioblastoma (GBM)—a highly aggressive brain cancer. Researchers found a subset ...
May 26, 2025
0
42
An interdisciplinary research team has demonstrated a durable and lasting response to a novel treatment—combined locoregional therapy and immunotherapy (LRT-IO)—for advanced liver cancer patients. The study marks the ...
May 25, 2025
0
48
A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have not responded to standard treatments, particularly those with EGFR-mutant non-small cell lung cancer ...
7 hours ago
0
0
Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to their critical treatment, paving the way for the development of more effective therapies. The study ...
May 28, 2025
0
0
